| Trial ID: | L1995 |
| Source ID: | NCT03102476
|
| Associated Drug: |
Humalog
|
| Title: |
Environmental Effects Type 1 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type1diabetes
|
| Interventions: |
DRUG: Humalog
|
| Outcome Measures: |
Primary: Area under the glucose infusion rate curve from 0 hours until the end of clamp., 1 Year|Onset of action, time from trial product administration until the blood glucose concentration has decreased at least 0.3 mmol/L (5 mg/dL) from the baseline, I year | Secondary: Area under the glucose infusion rate curve from 0 hours until 2 hours, 1 year|Area under the glucose infusion rate curve from 0 hours until 4 hours, 1 year|Area under the glucose infusion rate curve from 0 hours until 6 hours, 1 year|Area under the glucose infusion rate curve from 4 hours until 6 hours, 1 year|Maximum glucose infusion rate, 1 year|Time to maximum glucose infusion rate curve, 1 year
|
| Sponsor/Collaborators: |
Sponsor: University of Hull
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
|
| Enrollment: |
10
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2016-06
|
| Completion Date: |
2018-02-02
|
| Results First Posted: |
|
| Last Update Posted: |
2018-10-31
|
| Locations: |
Hull and East Yorkshire NHS Trust, Hull, HU32RW, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT03102476
|
